Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Payables (2016 - 2025)

National Research (NRC) has disclosed Payables for 16 consecutive years, with $8.8 million as the latest value for Q4 2025.

  • Quarterly Payables rose 0.63% to $8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2025, up 0.63% year-over-year, with the annual reading at $8.8 million for FY2025, 0.63% up from the prior year.
  • Payables hit $8.8 million in Q4 2025 for National Research, up from $7.8 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $12.8 million in Q1 2024 to a low of $5.1 million in Q1 2021.
  • Historically, Payables has averaged $9.4 million across 5 years, with a median of $9.0 million in 2023.
  • Biggest five-year swings in Payables: tumbled 51.34% in 2021 and later skyrocketed 124.01% in 2022.
  • Year by year, Payables stood at $9.3 million in 2021, then decreased by 7.18% to $8.6 million in 2022, then surged by 32.8% to $11.4 million in 2023, then decreased by 23.36% to $8.8 million in 2024, then increased by 0.63% to $8.8 million in 2025.
  • Business Quant data shows Payables for NRC at $8.8 million in Q4 2025, $7.8 million in Q3 2025, and $7.9 million in Q2 2025.